Table 1 Patient demographics and tumor characteristics in the endometrial cancer study cohort (n = 357)
Entire cohort | Dichotomized with iTFD-cutoff < / ≥ 6 mm | |||
|---|---|---|---|---|
iTFD ≥ 6 mm | iTFD < 6 mm | p valueα | ||
Age, median (range), years | 67 (30–93) | 64 (32–93) | 70 (30–89) | < 0.001 |
BMI, median (range), kg/m2 | 27 (16–53) | 28 (16–53) | 27 (16–50) | 0.03 |
Postmenopausal, n (%) | 327 (92) | 171 (87) | 156 (98) | < 0.001 |
FIGO stage, n (%) | 0.003 | |||
1 & 2 | 307 (86) | 179 (91) | 128 (80) | |
3 & 4 | 50 (14) | 18 (9) | 32 (20) | |
Myometrial invasion, n (%)* | < 0.001 | |||
< 50% | 211 (60) | 162 (83) | 49 (32) | |
≥ 50% | 139 (40) | 33 (17) | 106 (68) | |
Cervical stroma invasion, n (%)* | 0.001 | |||
No | 299 (85) | 177 (91) | 122 (79) | |
Yes | 51 (15) | 18 (9) | 33 (21) | |
Lymph node metastasis, n (%)** | 0.16 | |||
No | 213 (87) | 112 (90) | 101 (83) | |
Yes | 33 (13) | 13 (10) | 20 (17) | |
Histological type, n (%) | 0.79 | |||
Endometrioid | 290 (81) | 161 (82) | 129 (81) | |
Non-endometrioid | 67 (19) | 36 (18) | 31 (19) | |
Histological grade in endometrioid tumors, n (%)*** | < 0.001 | |||
Grade 1 | 160 (56) | 102 (65) | 58 (45) | |
Grade 2 | 77 (27) | 42 (27) | 35 (27) | |
Grade 3 | 50 (17) | 14 (9) | 36 (28) | |